SEC Filing Summary: Form 13F-HR
Business Context and Reporting Period
Company: Tompkins Financial Corp
Filing Type: Form 13F-HR (Quarterly Report of Holdings)
Reporting Period: As of July 8, 2004
This filing discloses the equity securities held by Tompkins Financial Corp at the end of the reporting period. The report details voting authority, share counts, and market values for a diversified portfolio of U.S. and international equities.
Key Financial Metrics
The filing provides aggregate data on the portfolio's composition and value. Specific corporate financial metrics (revenue, profit, cash flow) for Tompkins Financial Corp are not included in this form.
| Metric | Value |
|---|---|
| Total Portfolio Value | $314,184,000 |
| Total Shares Held | 7,739,159 |
| Shares with Sole Discretion | 7,126,402 |
| Shares with Shared/None Discretion | 612,757 |
Material Changes and Portfolio Composition
As a standalone 13F filing, this document does not provide comparative data against the prior period to calculate material changes. However, the portfolio composition reveals significant concentration in specific sectors:
- Top Holdings by Value: The portfolio is heavily weighted toward large-cap technology, healthcare, and financial services. Notable positions include General Electric ($12,011,000), Pfizer ($6,912,000), Intel ($6,398,000), and Microsoft ($5,059,000).
- Self-Holding: Tompkins Financial Corp holds a significant position in its own affiliate, Tompkins Trustco Inc, valued at $39,352,000 (828,472 shares).
- Discretionary Authority: The majority of holdings (approximately 92%) are held with "Sole" voting authority, indicating direct management control over these assets.
Guidance, Outlook, and Risks
Guidance and Outlook: Form 13F filings are historical disclosures of holdings and do not contain forward-looking guidance, management commentary, or earnings outlooks.
Risks and Contingencies: The filing does not disclose specific risk factors or contingencies. The portfolio's exposure to market risk is evident through its concentration in cyclical sectors such as technology (Intel, Cisco, Microsoft) and energy (Exxon Mobil, ChevronTexaco).
Key Facts for Investor Verification
- Total Exposure: Verify the total portfolio value of approximately $314.2 million against the firm's total assets under management to determine the scope of this specific reporting entity.
- Concentration Risk: Note the significant concentration in the top 10 holdings, which includes General Electric, Pfizer, Intel, Microsoft, and Tompkins Trustco Inc.
- Self-Ownership: Confirm the strategic intent behind the $39.4 million holding in Tompkins Trustco Inc, representing a substantial portion of the reported portfolio.
- Discretionary Control: Verify that the "Sole" voting authority on 7.1 million shares aligns with the firm's stated investment strategy and management structure.